Tamara Faranaz Ena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tamara Faranaz Ena has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Bahareh Rezaei
Department of Electrical and Computer Engineering, Texas Tech University, 910 Boston Ave, Lubbock, Texas, 79409, UNITED STATES
1 shared publication - Ebrahim Azizi
Texas Tech University, Lubbock, TX 79409, United States, Lubbock, Texas, 79409, United States
1 shared publication - Hanlei Wang
University of South Florida
1 shared publication - Hansong Zuo
Lubbock High School, 2004 19th St, Lubbock, Texas, 79401-4606, United States
1 shared publication - Ioannis Karampelas
Nemak USA, Inc., 3101 S Taylor Dr, Sheboygan, Wisconsin, 53081, United States
1 shared publication - Jaiden Hart
Department of Electrical and Computer Engineering, Texas Tech University, 910 Boston Ave, Lubbock, Texas, 79409, UNITED STATES
1 shared publication
Latest Publications
- Open Access
- 19 February 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (2) , 022001
Magnetic nanoparticles for cancer theranostics
Magnetic nanoparticles (MNPs) have emerged as a powerful tool in cancer theranostics due to their unique size-dependent magnetic properties, surface functionalization capabilities, and responsiveness to external magnetic fields. This review outlines different types of MNPs, including those composed of pure metals, metal oxides, and metallic alloys, and highlights their size-dependent magnetic behavior, such as superparamagnetism and dynamic magnetizations. We also explore the critical role of surface modification strategies in enhancing MNPs’ biocompatibility, colloidal stability, and functional versatility for targeted biomedical applications. The applications of MNPs in cancer therapy are discussed, with a focus on magnetic hyperthermia, drug and gene delivery, and a combination of various therapies. Additionally, we examine their cancer diagnostic roles in imaging techniques such as magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), and emerging magnetic biosensing technologies such as giant magnetoresistance (GMR), magnetic tunnel junction (MTJ), magnetic particle spectroscopy (MPS), and nuclear magnetic resonance (NMR)-based platforms. These advances collectively establish MNPs as key components in the future of personalized cancer diagnosis and treatment.
- 19 February 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (2) , 022001
Open AccessMagnetic nanoparticles for cancer theranostics
Magnetic nanoparticles (MNPs) have emerged as a powerful tool in cancer theranostics due to their unique size-dependent magnetic properties, surface functionalization capabilities, and responsiveness to external magnetic fields. This review outlines different types of MNPs, including those composed of pure metals, metal oxides, and metallic alloys, and highlights their size-dependent magnetic behavior, such as superparamagnetism and dynamic magnetizations. We also explore the critical role of surface modification strategies in enhancing MNPs’ biocompatibility, colloidal stability, and functional versatility for targeted biomedical applications. The applications of MNPs in cancer therapy are discussed, with a focus on magnetic hyperthermia, drug and gene delivery, and a combination of various therapies. Additionally, we examine their cancer diagnostic roles in imaging techniques such as magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), and emerging magnetic biosensing technologies such as giant magnetoresistance (GMR), magnetic tunnel junction (MTJ), magnetic particle spectroscopy (MPS), and nuclear magnetic resonance (NMR)-based platforms. These advances collectively establish MNPs as key components in the future of personalized cancer diagnosis and treatment.